Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Generalized Anxiety Disorder
Recent news which mentions Generalized Anxiety Disorder
Psychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In Colorado
March 22, 2024
Tickers
CCC
IXHL
Tags
IXHL
Market News
Colorado
From
Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
March 07, 2024
Tickers
CMPS
MNMD
NEWS
Tags
Biotech
Breakthrough Therapy Drug
Generalized Anxiety Disorder
From
Benzinga
Psilocybin-Assisted Therapy Achieves Positive Clinical Trial Results For Treating Generalized Anxiety
February 28, 2024
Tickers
IXHL
NEWS
Tags
Benzinga
Psychedelics
Biotech
From
Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
Tickers
MNMD
NEWS
Tags
LSD Therapy
News
Generalized Anxiety Disorder
From
Benzinga
Groundbreaking Study: LSD Tartrate Reduces Anxiety Effectively, Says MindMed
December 14, 2023
Tickers
MNMD
Tags
Management
Generalized Anxiety Disorder
Penny Stocks
From
Benzinga
MindMed's Phase 2b Trial For MM-120 In GAD Reaches Enrollment Milestone
September 12, 2023
Tickers
MNMD
Tags
Generalized Anxiety Disorder
MNMD
Penny Stocks
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Benzinga
Markets
Market News
From
Benzinga
Trial On DMT Drug For Anxiety And Depression Ends Participant Dosing, Study Results Soon Released
May 09, 2023
Tickers
CYBN
Tags
DMT Entities
Generalized Anxiety Disorder
News
From
Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
March 15, 2023
Tickers
FLHLF
IXHL
SILO
Tags
Markets
Benzinga
FDA
From
Benzinga
Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing
January 24, 2023
Tickers
AWKNF
Tags
Psilocybin program
Generalized Anxiety Disorder
Ketamine Therapy
From
Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
January 18, 2023
Tickers
IXHL
Tags
Generalized Anxiety Disorder
News
Psilocybin program
From
Benzinga
Psychedelics Companies Join The Race To Develop Much-Needed Anxiety Treatment
January 16, 2023
Tickers
CYBN
Tags
Market News
Psychedelics/Assisted Therapy
CYBN
From
Benzinga
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans
January 09, 2023
Tickers
CYBN
MNMD
Tags
CYBN
Market News
Cannabis
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
Cannabis
AWKNF
ENVB
From
Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
Tags
Small Cap
News
MindMed
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.